Background: The impact of the SARS-CoV-2 pandemic on managing liver malignancies worldwide is unknown. This study aimed to determine the impact of lockdowns on patient clinical pathways and postoperative morbi-mortality.
Methods: This study evaluated all adults' hospital stays for liver tumors between 2019 and 2021 from the national French discharge database.